Transplantation of multipotent mesenchymal stromal adipose tissue cells to a patient with stage IV resistant GVHD - a clinical case

V. S. Sergeev

Genes & Cells ›› 2006, Vol. 1 ›› Issue (4) :27 -28.

Cloning

brief-report

Transplantation of multipotent mesenchymal stromal adipose tissue cells to a patient with stage IV resistant GVHD - a clinical case

V. S. Sergeev

Author information +

History +

Abstract

Cite this article

Download citation ▾

V. S. Sergeev. Transplantation of multipotent mesenchymal stromal adipose tissue cells to a patient with stage IV resistant GVHD - a clinical case. Genes & Cells, 2006, 1(4): 27-28 DOI:

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Butcher B., Collins R. The graft-versus-lymphoma effect: clinical review and future opportunities. Bone Marrow Transplant. 2005, 36(1): 1-17.

[2]	Bregni M., Ueno N., Childs R. The Second International Meeting on Allogeneic Transplantation in Solid Tumors. Bone Marrow Transplant. Advance online publication September 4, 2006.

[3]	Yanez R., Lamana M., Garcia-Castro J. et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosupressive properties applicable for the control of the graft-versus-host disease (GVHD). Stem Cells. Advance online publication July 27, 2006.

[4]	Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105(4): 1815-22.

[5]	Ringden O., Le Blanc K., Rasmusson I. et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplant. 2006; 81(10): 1390-7.

[6]	Cao Y., Sun Z., Liao L. et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem. Biophys. Res. Commun. 2005, 332: 370Œ9.

[7]

Pongers-Willemse M., Seriu T., Stolz F. et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110Œ8.